The ZCCHC12 gene is associated with non-syndromic mental retardation, a condition characterized by intellectual disabilities that do not coincide with other physical or neurological symptoms. Genetic testing for mutations in the ZCCHC12 gene can help in diagnosing this specific form of mental retardation, allowing for better-informed decisions regarding management and care. DNA Labs UAE offers a specialized genetic test to identify mutations in the ZCCHC12 gene. The cost of this test is 4400 AED. By undergoing this test, individuals can gain valuable insights into their genetic makeup, potentially leading to early intervention and support strategies that can improve quality of life.
The "WDR81 Gene Mental Retardation with Cerebellar Ataxia and Dysequilibrium Syndrome Type 2 Genetic Test" is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the WDR81 gene. These mutations are linked to a rare genetic disorder characterized by intellectual disability, impaired coordination (cerebellar ataxia), and balance issues (dysequilibrium syndrome type 2). The test, priced at 4400 AED, is crucial for accurate diagnosis, enabling targeted management and therapy plans for affected individuals. Through advanced genetic analysis, DNA Labs UAE offers families and healthcare professionals vital information for understanding and addressing the complex needs associated with this condition.
The ATRX Gene Mental Retardation with Hypotonic Facies Syndrome X-Linked Genetic Test is a specialized diagnostic procedure designed to identify mutations in the ATRX gene, which are associated with a rare genetic condition. This condition, often referred to as ATR-X syndrome, is characterized by intellectual disability, facial dysmorphism, and other physical abnormalities. The test plays a crucial role in the early diagnosis and management of the syndrome, enabling healthcare professionals to provide targeted interventions and support for affected individuals.
Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, the test involves collecting a DNA sample from the patient, usually through a blood draw or cheek swab. The sample is then analyzed for specific mutations in the ATRX gene that are known to cause the syndrome.
The cost of the ATRX Gene Mental Retardation with Hypotonic Facies Syndrome X-Linked Genetic Test is set at 4400 AED. This price reflects the comprehensive nature of the test, including the sophisticated technology and expertise required to accurately identify the genetic mutations associated with the condition. Patients considering this test are advised to consult with their healthcare provider to understand its benefits and implications fully.
The FOXP1 gene test is a specialized genetic analysis designed to identify mutations in the FOXP1 gene, which is known to be associated with mental retardation, language impairment, and autistic features. This test is particularly relevant for individuals showing symptoms of these conditions, as it can provide a definitive diagnosis and help guide treatment and management strategies.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, usually through a blood draw or a cheek swab, and then analyzing the genetic material for specific mutations in the FOXP1 gene. These mutations can disrupt normal brain development and function, leading to the observed symptoms.
The cost of the FOXP1 gene test at DNA Labs UAE is 4400 AED. While the price might seem significant, the value of the insights gained from this test can be immeasurable for affected individuals and their families. It not only aids in understanding the condition better but also opens up avenues for targeted interventions and supports that can significantly improve the quality of life for those diagnosed with disorders linked to the FOXP1 gene.
Given the complexity of the disorders associated with FOXP1 mutations, this test is a crucial tool in the arsenal of healthcare providers, enabling them to offer personalized care plans based on genetic information.
The SMARCA1 gene plays a crucial role in regulating gene expression and is involved in chromatin remodeling. Mutations in the SMARCA1 gene have been associated with X-linked mental retardation and other developmental disorders. The genetic test for SMARCA1-related conditions is designed to identify mutations in the SMARCA1 gene that may lead to intellectual disabilities and other symptoms associated with the disorder.
At DNA Labs UAE, a specialized genetic test is offered to diagnose conditions related to mutations in the SMARCA1 gene. This test is particularly important for families with a history of X-linked mental retardation or for individuals showing symptoms related to SMARCA1 mutations. Early diagnosis through genetic testing can aid in understanding the condition better, allowing for appropriate management and support.
The cost of the SMARCA1 Gene Mental Retardation X-linked SMARCA1 Related Genetic Test at DNA Labs UAE is 4400 AED. This comprehensive test is conducted by experienced professionals using advanced genetic testing technologies to ensure accuracy and reliability of the results. By opting for this test, individuals can gain valuable insights into their genetic makeup, paving the way for personalized medical care and interventions tailored to their specific needs.
The KDM5C Gene Mental Retardation X-linked Syndromic Claes-Jensen Type Genetic Test is a specialized diagnostic procedure designed to identify mutations in the KDM5C gene, which are linked to Claes-Jensen type mental retardation. This condition is an X-linked syndrome, meaning it primarily affects males and is passed down through the maternal line. Symptoms can include intellectual disability, developmental delays, and sometimes physical abnormalities.
This genetic test involves analyzing the patient's DNA, extracted from a blood sample, to look for specific mutations in the KDM5C gene that are known to cause the syndrome. The process is highly accurate and can provide crucial information for families regarding prognosis, management, and genetic counseling.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test ensures confidentiality, precision, and reliability. The cost of the test is set at 4400 AED, reflecting the sophisticated technology and expertise required to perform this intricate analysis. For families facing the challenges of X-linked mental retardation syndromes, this test represents a vital step towards understanding and managing the condition.
The MECP2 Gene Mental Retardation X-linked Syndromic Lubs Type Genetic Test is a specialized diagnostic tool designed to detect mutations in the MECP2 gene, which are associated with Lubs type X-linked mental retardation. This condition, part of a spectrum of MECP2-related disorders, is characterized by intellectual disability, developmental delays, and sometimes physical abnormalities. The test is crucial for early diagnosis and intervention, providing valuable information for managing the condition and counseling affected families.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test employs advanced genetic sequencing techniques to analyze the MECP2 gene for any abnormalities that may indicate the presence of the disorder. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the MECP2 gene. By opting for this test, individuals and families gain access to crucial genetic information that can guide clinical management and therapeutic strategies, ultimately enhancing the quality of life for those affected by Lubs type X-linked mental retardation.
The "SOBP Gene Mental Retardation, Anterior Maxillary Protrusion, and Strabismus Genetic Test" is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the SOBP gene that are associated with a specific syndrome characterized by intellectual disability, forward protrusion of the upper jaw, and strabismus (crossed eyes). This genetic testing is crucial for early diagnosis and management of the condition, enabling healthcare providers to offer personalized treatment plans and supportive care for affected individuals. The test is conducted using advanced genomic technologies to analyze the patient's DNA, ensuring high accuracy and reliability. The cost of the test is 4400 AED, reflecting the comprehensive analysis and detailed insights it provides into the patient's genetic makeup, which can significantly impact their treatment and management plan.
The POMK gene limb-girdle muscular dystrophy autosomal recessive type 12C genetic test is a specialized diagnostic procedure aimed at identifying mutations in the POMK gene, which are responsible for causing limb-girdle muscular dystrophy type 12C (LGMDR12). This form of muscular dystrophy is characterized by progressive weakness and wasting of the limb-girdle muscles, which are the muscles around the shoulders and hips. Early symptoms often include difficulty walking or climbing stairs, and the condition can progressively lead to more severe mobility issues.
The test is conducted by DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities. The procedure involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any genetic mutations in the POMK gene. Identifying these mutations can confirm a diagnosis of LGMDR12, which is crucial for the management and treatment of the condition.
The cost of the test is set at 4400 AED, reflecting the specialized nature of the analysis and the expertise required to accurately interpret the results. For individuals showing symptoms of limb-girdle muscular dystrophy or those with a family history of the condition, this test provides a valuable diagnostic tool. It not only aids in confirming the specific type of muscular dystrophy but also helps in guiding treatment decisions and genetic counseling for affected families.
The CAPN3 gene is associated with a condition known as Limb-girdle muscular dystrophy type 2A (LGMD2A), which is an autosomal recessive disorder. This condition primarily affects the muscles around the hips and shoulders (the limb-girdle area), leading to progressive weakness and wasting. The CAPN3 gene encodes for a protein called calpain 3, which plays a crucial role in muscle function and repair. Mutations in the CAPN3 gene disrupt the normal functioning of calpain 3, leading to the symptoms observed in LGMD2A.
To diagnose this condition, genetic testing of the CAPN3 gene can be performed. This test looks for mutations in the CAPN3 gene that are known to cause Limb-girdle muscular dystrophy type 2A. It is a vital tool for confirming the diagnosis, understanding the disease's progression, and making informed decisions about management and treatment.
In the United Arab Emirates, DNA Labs UAE offers this genetic test for individuals suspected of having LGMD2A or for those who may be carriers of the condition. The test cost is 4400 AED. Conducting this test at DNA Labs UAE provides a reliable diagnosis, aiding in the proper management of the condition and potentially guiding family planning decisions for affected individuals or families.
